Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
Clinical trial NCT02902874 · COMPLETED
Trial details
- NCT number
- NCT02902874
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-21
- Primary completion
- 2020-12-31
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.